Hypertonic saline, developed into an effective treatment at UNC School of Medicine in collaboration with Australian researchers, has become a proven therapy for thousands of people with cystic fibrosis.
The discovery from UNC School of Medicine researchers overturns a controversial research study and offers a path for creating and testing CF treatments.
The discovery could lead to new therapies and better diagnostics, resulting in fewer hospitalizations of children with respiratory syncytial virus, the leading cause of severe lung infection in babies.
